Adaptimmune Therapeutics plc

ADAP · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Assets
Cash & Equivalents$26,061$41,054$91,139$116,741
Short-Term Investments$0$18,509$60,466$69,349
Receivables$28,895$20,852$15,982$38,614
Inventory$11,411$11,759$7,320$1,874
Other Curr. Assets$11,748$10,824$13,262$17,636
Total Curr. Assets$78,115$102,998$188,169$244,214
Property Plant & Equip (Net)$46,900$48,941$51,218$65,290
Goodwill$0$0$0$0
Intangibles$3,807$3,806$3,880$4,283
Long-Term Investments$1,717$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$94$2,327$2,696$3,649
Total NC Assets$52,518$55,074$57,794$73,222
Other Assets$0$0$0$0
Total Assets$130,633$158,072$245,963$317,436
Liabilities
Payables$9,418$5,701$8,692$9,069
Short-Term Debt$9,028$9,254$9,418$8,350
Tax Payable$0$0$0$0
Deferred Revenue$10,700$12,444$12,296$18,709
Other Curr. Liab.$22,367$23,673$34,121$27,329
Total Curr. Liab.$51,513$51,072$64,527$63,457
LT Debt$44,166$44,079$69,500$70,320
Deferred Rev, NC$101,419$95,979$95,815$98,731
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,493$4,371$4,272$4,939
Total NC Liab.$150,078$144,429$169,587$173,990
Other Liabilities$0$0$0$0
Cap. Leases$23,005$23,295$23,972$24,630
Total Liabilities$201,591$195,501$234,114$237,447
Equity
Pref Stock$0$0$0$0
Common Stock$2,156$2,099$2,085$2,084
Retained Earnings-$1,171,911-$1,141,571-$1,093,987-$1,019,772
AOCI-$10,612-$4,412-$1,902-$5,136
Other Equity$1,109,409$1,106,455$1,105,653$1,102,813
Total Equity-$70,958-$37,429$11,849$79,989
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$130,633$158,072$245,963$317,436
Net Debt$27,133$12,279-$12,221-$38,071
Adaptimmune Therapeutics plc (ADAP) Financial Statements & Key Stats | AlphaPilot